Neurobiological trait abnormalities in bipolar disorder (Q37489488)

20 August 2017

1 reference

title

Neurobiological trait abnormalities in bipolar disorder (English)

1 reference

20 August 2017

1 reference

C Langan

1

1 reference

20 August 2017

C McDonald

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

19 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

14

1 reference

20 August 2017

issue

9

1 reference

20 August 2017

page(s)

833-846

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2009.39

20 August 2017

exact match

0 references

cites work

Toward constructing an endophenotype strategy for bipolar disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neuropsychological function in euthymic patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neuropsychology of bipolar disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regulation of the HPA axis by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Immune-neuro-endocrine interactions: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Depression and immune function: central pathways to morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The pathophysiologic roles of interleukin-6 in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Immunologic variables in acute mania of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cytokine production in bipolar affective disorder patients under lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The glucocorticoid receptor: part of the solution or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

A relative resistance of T cells to dexamethasone in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Altered glucocorticoid immunoregulation in treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Protein kinase A activity in platelets from patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Hyperfunctional G proteins in mononuclear leukocytes of patients with mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Is lithium response related to G(s)alpha levels in transformed lymphoblasts from subjects with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Signaling: cellular insights into the pathophysiology of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Molecular evidence for mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Computerised tomographic scan changes in manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Meta-analysis of brain size in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

MRI investigation of temporal lobe structures in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regional prefrontal gray and white matter abnormalities in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Anterior cingulate subregion volumes and executive function in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regional cerebral cortical thinning in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regional gray matter changes in bipolar disorder: a voxel-based morphometric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Changes in gray matter volume in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Voxel-based study of structural changes in first-episode patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Greater cortical gray matter density in lithium-treated patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

White matter hyperintensities in subjects with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Cortical white matter microstructural abnormalities in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Magnetic resonance imaging abnormalities in young euthymic patients with bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Familial leukoencephalopathy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Reduced left hemispheric white matter volume in twins with bipolar I disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Association of Genetic Risks for Schizophrenia and Bipolar DisorderWith Specific and Generic Brain Structural Endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Neurobiology of emotion perception II: Implications for major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Lithium and increased cortical gray matter-more tissue or more water?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Increased anterior cingulate and caudate activity in bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The nature of abnormal language processing in euthymic bipolar I disorder: evidence for a relationship between task demand and prefrontal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

An emotional Stroop functional MRI study of euthymic bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Major depression and activation of the inflammatory response system

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Illness, cytokines, and depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Plasma cortisol in depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Lithium-induced increase in human brain grey matter

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Decreased temporal lobe phosphomonoesters in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Abnormal frontal lobe phosphorous metabolism in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.39

7 January 2021

Identifiers

DOI

10.1038/MP.2009.39

1 reference

20 August 2017

1 reference